Quantitative Systematic Strategies’s Ascendis Pharma A/S ASND Stock Holding History

Quantitative Systematic Strategies’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,230	Closed	-$251K	–	571
2020 Q1	$251K	Sell	2,230 -4,419	-66%	-$574K	0.21%	174
2019 Q4	$925K	Buy	+6,649	New	+$739K	0.14%	238
2019 Q2	–	Sell	-2,198	Closed	-$259K	–	468
2019 Q1	$259K	Sell	2,198 -2,518	-53%	-$221K	0.06%	272
2018 Q4	$295K	Sell	4,716 -485	-9%	-$30.5K	0.07%	418
2018 Q3	$369K	Sell	5,201 -229	-4%	-$15.8K	0.07%	371
2018 Q2	$361K	Buy	+5,430	New	+$357K	0.07%	421
2018 Q1	–	Sell	-6,714	Closed	-$269K	–	622
2017 Q4	$269K	Buy	+6,714	New	+$244K	0.07%	426
2016 Q3	–	Sell	-11,925	Closed	-$162K	–	376
2016 Q2	$162K	Buy	+11,925	New	+$184K	0.08%	377

Other funds holding ASND

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Quantitative Systematic Strategies's ASND Position: Q2 2020 in Review

Quantitative Systematic Strategies sold out of Ascendis Pharma A/S (ASND) in Q2 2020, closing a stake of 2,230 shares — an estimated $251K sold.

Quantitative Systematic Strategies first reported a position in ASND in Q2 2016 and held it in 8 quarters. The position peaked at $925K in Q4 2019. 154 funds tracked by Wall St. Rank hold ASND as of Q2 2020.

Quantitative Systematic Strategies reported no remaining Ascendis Pharma A/S position as of Q2 2020 after selling out during the quarter.
Quantitative Systematic Strategies sold 2,230 Ascendis Pharma A/S shares in Q2 2020, an estimated $251K.
Quantitative Systematic Strategies first reported a position in Ascendis Pharma A/S in Q2 2016 and held it in 8 quarters.
Quantitative Systematic Strategies's Ascendis Pharma A/S position peaked at $925K in Q4 2019.
154 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2020, filed 4 Aug 2020.